Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

May 9, 2024

Study Completion Date

May 9, 2024

Conditions
Hemophilia
Interventions
DRUG

SEVENFACT®

Coagulation Factor VIIa (Recombinant)

Trial Locations (8)

13210

SUNY Upstate Medical University, Pediatric Hematology/Oncology, Syracuse

19104

Hospital of the University of Pennsylvania, Philadelphia

30322

Children's healthcare of Atlanta, Atlanta

44106

University Hospitals Cleveland Medical Center, Cleveland

55905

Mayo Clinic, Rochester

77030

The Gulf States Hemophilia & Thrombophilia Center, Houston

90007

Luskin Orthopaedic Institute for Children, Los Angeles

93636

Valley Children's Hospital, Madera

All Listed Sponsors
lead

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

NCT05904210 - Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® | Biotech Hunter | Biotech Hunter